Vito Imbasciani, PhD, MD, Board Chair and Jonathan Thomas, PhD, JD, Interim President and CEO South San Francisco, CA, Dec. 15, 2023 - The Independent Citizens Oversight Committee (ICOC), the governing board of the California Institute for Regenerative Medicine (CIRM), named Jonathan Thomas, PhD, JD as CIRM’s Interim President and CEO at the Dec. 14 meeting. … Continue reading CIRM Announces Interim CEO
Month: December 2023
Statement from CIRM on the FDA Approval of Gene Therapies for Sickle Cell Disease
The California Institute for Regenerative Medicine (CIRM) applauds and acknowledges the historic significance of the Food and Drug Administration (FDA) approval of Vertex and CRISPR Therapeutics’ CRISPR-based gene therapy (Casgevy) for sickle cell disease. As the first regulatory authorization of a CRISPR-based gene editing therapy in the world, this brings forth a new era of treatment options … Continue reading Statement from CIRM on the FDA Approval of Gene Therapies for Sickle Cell Disease
CIRM invests $17.5 million in clinical-stage research, including Phase 2 spina bifida trial
Diana Farmer, MD and Aijun Wang, PhD. Photo courtesy UC Davis Health South San Francisco, CA – The California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, has awarded $17.5 million to fund clinical-stage research projects aimed at advancing stem cell and gene therapy treatments for a variety of conditions … Continue reading CIRM invests $17.5 million in clinical-stage research, including Phase 2 spina bifida trial
CIRM Joins World AIDS Day Campaign, Commits $104 Million for HIV Research
John A. Zaia, MD, of Beckman Research Institute of City of Hope This year marks the 35th commemoration of World AIDS Day, a global event that aims to end human immunodeficiency virus (HIV) related stigma, honor people lost to the disease, and reaffirm the commitment to ensuring HIV is no longer a public health threat. … Continue reading CIRM Joins World AIDS Day Campaign, Commits $104 Million for HIV Research
The Stem Cellar 